US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Attovia Therapeutics

16.21

-0.1000-0.61%

Post-market: 16.210.00000.00%17:30 EDT

Volume:194.20K

Turnover:3.20M

Market Cap:740.01M

PE:-10.51

High:16.94

Open:16.44

Low:15.98

Close:16.31

52wk High:28.00

52wk Low:15.48

Shares:45.65M

Float Shares:17.00M

Volume Ratio:0.43

T/O Rate:1.14%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.5420

EPS(LYR):-15.3508

ROE:--

ROA:--

PB:-5.09

PE(LYR):-1.06

Loading ...

Overview Company News Filings

Attovia Therapeutics to Present New Data on ATTO-1310 and ATTO-2306 at EADV 2026 and Fall Clinical Dermatology Conference 2026

Attovia Therapeutics to Participate in Upcoming Investor Conferences

Sam Slutsky Reiterates Buy on Attovia, Maintains $45 Price Target on Strong Early ATTO-1310 Data and Robust Cash Runway

Analysts Offer Insights on NA Companies: Fastenal Company (FAST) and Attovia Therapeutics, Inc. (ATTO)

Attovia Q2 FY26 Net Loss Widens to $20.7 Million; Revenue Rises to $0.5 Million

Attovia Therapeutics Q2 EPS $(4.88) Misses $(4.62) Estimate, Sales $450.000K

Benzinga Earnings

Attovia Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update

THOMSON REUTERS

Attovia Therapeutics - Q2 Collaboration Revenue was $0.50 Mln

THOMSON REUTERS

Attovia Therapeutics - Q2 Net Loss was $20.70 Mln

THOMSON REUTERS

Attovia Therapeutics Could Serve as Key Player in Immunology, Inflammation, RBC Says

MT Newswires Live

Attovia Therapeutics Initiated at Buy by Citigroup

Morgan Stanley Initiates Coverage on Attovia Therapeutics With Overweight Rating

MT Newswires Live

Attovia Therapeutics Inc : Leerink Partners Initiates Coverage with Outperform Rating; Target Price $52

THOMSON REUTERS

RBC Initiates Attovia Therapeutics at Outperform, Speculative Risk With $45 Price Target

MT Newswires Live

Citigroup Initiates Attovia Therapeutics at Buy With $30 Price Target

MT Newswires Live

Attovia initiated with a Buy at Citi

Attovia initiated with an Overweight at Morgan Stanley

U.S. Research Roundup-Adobe, Braveheart Bio, CACI International

Attovia Therapeutics, Inc. (ATTO) Initiated with a Buy at RBC Capital

Goldman Sachs Reports Sale of 105,807 Attovia Therapeutics Shares Worth $2.22 Million

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigrgood.cn/stock/ATTO/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"ATTO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ATTO\",,,,,undefined,":{"symbol":"ATTO","market":"US","secType":"STK","nameCN":"Attovia Therapeutics","latestPrice":16.21,"timestamp":1791576000000,"preClose":16.31,"halted":0,"volume":194199,"hourTrading":{"tag":"盘后","latestPrice":16.21,"preClose":16.21,"latestTime":"17:30 EDT","volume":1432,"amount":23212.72,"timestamp":1791581414603,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.006131207847945915,"floatShares":17000000,"shares":45651262,"eps":-1.542,"marketStatus":"Post-Mkt","change":-0.1,"latestTime":"10-09 17:50:56 EDT","open":16.44,"high":16.94,"low":15.98,"amount":3199492.028073,"amplitude":0.05886,"askPrice":16.88,"askSize":1,"bidPrice":15,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-1.542,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1791590400000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1785902400000,"exchange":"NASDAQ","adjPreClose":16.31,"postHourTrading":{"tag":"盘后","latestPrice":16.21,"preClose":16.21,"latestTime":"17:30 EDT","volume":1432,"amount":23212.72,"timestamp":1791581414603,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.429633},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ATTO\",,,,,undefined,":{"symbol":"ATTO","floatShares":17000000,"roa":"--","roe":"--","lyrEps":-15.350764,"volumeRatio":0.429633,"shares":45651262,"dividePrice":0,"high":16.94,"amplitude":0.05886,"preClose":16.31,"low":15.98,"week52Low":15.48,"pbRate":"-5.09","psRate":"411.11","week52High":28,"institutionHeld":0,"latestPrice":16.21,"committee":0.99005,"eps":-1.542,"divideRate":0,"volume":194199,"delay":0,"ttmEps":-1.542,"open":16.44,"prevYearClose":17,"prevWeekClose":17.17,"prevMonthClose":17.14,"prevQuarterClose":17.14,"fiveDayClose":17.17,"twentyDayClose":22.79,"sixtyDayClose":17},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ATTO\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ATTO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ATTO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.6,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":5,"updateTime":1788408000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ATTO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ATTO","date":"2026-10-08","current":-10.512322,"percent":0.09165,"low":-16.572744,"twenty":-6.493497,"median":-0.849705,"eighty":-0.300743,"high":-0.053299,"avg":-3.404282,"sd":4.187142,"marketCap":749593722},"quantilePoints":[{"date":"2021-10-15","current":-6.926526,"twenty":-20.264397,"median":-4.849117,"eighty":34.053766,"marketCap":388183291},{"date":"2021-10-22","current":-6.816143,"twenty":-20.264397,"median":-4.866242,"eighty":33.744187,"marketCap":381997104},{"date":"2021-10-29","current":-6.056006,"twenty":-20.264397,"median":-4.898694,"eighty":33.372691,"marketCap":339396764},{"date":"2021-11-05","current":-6.166389,"twenty":-20.264397,"median":-4.92467,"eighty":32.879679,"marketCap":345582952},{"date":"2021-11-12","current":-6.665621,"twenty":-20.264397,"median":-4.951727,"eighty":32.351078,"marketCap":373561393},{"date":"2021-11-19","current":-6.630774,"twenty":-20.264397,"median":-4.977858,"eighty":32.196288,"marketCap":362219315},{"date":"2021-11-26","current":-6.084254,"twenty":-20.264397,"median":-5.01026,"eighty":32.196288,"marketCap":332364520},{"date":"2021-12-03","current":-6.01691,"twenty":-20.264397,"median":-5.060604,"eighty":32.041498,"marketCap":328685730},{"date":"2021-12-10","current":-5.998779,"twenty":-20.264397,"median":-5.098942,"eighty":32.041498,"marketCap":327695286},{"date":"2021-12-17","current":-5.889993,"twenty":-20.264397,"median":-5.144243,"eighty":32.041498,"marketCap":321752626},{"date":"2021-12-23","current":-5.931435,"twenty":-20.264397,"median":-5.175618,"eighty":32.041498,"marketCap":324016496},{"date":"2021-12-31","current":-6.612643,"twenty":-20.264397,"median":-5.213956,"eighty":32.041498,"marketCap":361228871},{"date":"2022-01-07","current":-7.283491,"twenty":-20.264397,"median":-5.271462,"eighty":31.936925,"marketCap":397875279},{"date":"2022-01-14","current":-6.832806,"twenty":-20.264397,"median":-5.3098,"eighty":15.90285,"marketCap":373255684},{"date":"2022-01-21","current":-6.255203,"twenty":-20.264397,"median":-5.328969,"eighty":15.309035,"marketCap":341702986},{"date":"2022-01-28","current":-5.913304,"twenty":-20.264397,"median":-5.367307,"eighty":14.959254,"marketCap":323026053},{"date":"2022-02-04","current":-6.231892,"twenty":-20.264397,"median":-5.386476,"eighty":14.7408,"marketCap":340429559},{"date":"2022-02-11","current":-6.138647,"twenty":-20.264397,"median":-5.424814,"eighty":14.601337,"marketCap":335335850},{"date":"2022-02-18","current":-6.708479,"twenty":-20.264397,"median":-5.453568,"eighty":14.251556,"marketCap":366464072},{"date":"2022-02-25","current":-6.477956,"twenty":-20.264397,"median":-5.474464,"eighty":14.007523,"marketCap":353871291},{"date":"2022-03-04","current":-6.345858,"twenty":-20.264397,"median":-5.492672,"eighty":13.722817,"marketCap":346655204},{"date":"2022-03-11","current":-6.281105,"twenty":-20.264397,"median":-5.520659,"eighty":13.473423,"marketCap":343117906},{"date":"2022-03-18","current":-7.423359,"twenty":-20.264397,"median":-5.565933,"eighty":-0.776884,"marketCap":405515842},{"date":"2022-03-25","current":-7.692734,"twenty":-20.264397,"median":-5.587433,"eighty":-0.807204,"marketCap":420231002},{"date":"2022-04-01","current":-4.265262,"twenty":-20.264397,"median":-5.617005,"eighty":-0.827193,"marketCap":396460359},{"date":"2022-04-08","current":-4.186106,"twenty":-20.264397,"median":-5.617005,"eighty":-0.850226,"marketCap":389102780},{"date":"2022-04-14","current":-3.820774,"twenty":-20.264397,"median":-5.617005,"eighty":-0.866168,"marketCap":355144719},{"date":"2022-04-22","current":-3.656374,"twenty":-20.264397,"median":-5.617005,"eighty":-0.908405,"marketCap":339863591},{"date":"2022-04-29","current":-3.874051,"twenty":-20.264397,"median":-5.617005,"eighty":-1.025402,"marketCap":360096936},{"date":"2022-05-06","current":-3.68834,"twenty":-20.264397,"median":-5.617005,"eighty":-1.181138,"marketCap":342834922},{"date":"2022-05-13","current":-1.421233,"twenty":-20.264397,"median":-5.617005,"eighty":-1.328409,"marketCap":203720925},{"date":"2022-05-20","current":-1.443487,"twenty":-20.264397,"median":-5.617005,"eighty":-1.405048,"marketCap":206910861},{"date":"2022-05-27","current":-0.973115,"twenty":-20.264397,"median":-5.617005,"eighty":-1.405048,"marketCap":139487210},{"date":"2022-06-03","current":-1.318054,"twenty":-20.264397,"median":-5.617005,"eighty":-1.405048,"marketCap":188931221},{"date":"2022-06-10","current":-1.261407,"twenty":-20.264397,"median":-5.617005,"eighty":-1.405048,"marketCap":180811383},{"date":"2022-06-17","current":-1.153171,"twenty":-20.264397,"median":-5.617005,"eighty":-1.405048,"marketCap":165296694},{"date":"2022-06-24","current":-1.052016,"twenty":-20.264397,"median":-5.617506,"eighty":-1.411407,"marketCap":150796984},{"date":"2022-07-01","current":-0.959964,"twenty":-20.264397,"median":-5.617506,"eighty":-1.411407,"marketCap":137602247},{"date":"2022-07-08","current":-0.939733,"twenty":-20.264397,"median":-5.617506,"eighty":-1.411407,"marketCap":134702305},{"date":"2022-07-15","current":-0.829474,"twenty":-20.264397,"median":-5.617506,"eighty":-1.411407,"marketCap":118897622},{"date":"2022-07-22","current":-0.85274,"twenty":-20.264397,"median":-5.617506,"eighty":-1.411407,"marketCap":122232555},{"date":"2022-07-29","current":-0.862855,"twenty":-20.264397,"median":-5.617506,"eighty":-1.411407,"marketCap":123682526},{"date":"2022-08-05","current":-0.632806,"twenty":-20.264397,"median":-5.617506,"eighty":-1.411407,"marketCap":89028219},{"date":"2022-08-12","current":-0.612193,"twenty":-20.264397,"median":-5.617506,"eighty":-1.411407,"marketCap":86128277},{"date":"2022-08-19","current":-0.559631,"twenty":-20.264397,"median":-5.617506,"eighty":-1.411407,"marketCap":78733425},{"date":"2022-08-26","current":-0.546233,"twenty":-20.264397,"median":-5.617506,"eighty":-1.411407,"marketCap":76848463},{"date":"2022-09-02","current":-0.54881,"twenty":-20.264397,"median":-5.617506,"eighty":-1.411407,"marketCap":77210955},{"date":"2022-09-09","current":-0.544172,"twenty":-20.264397,"median":-5.617506,"eighty":-1.411407,"marketCap":76558468},{"date":"2022-09-16","current":-0.498824,"twenty":-20.264397,"median":-5.617506,"eighty":-1.411407,"marketCap":70178596},{"date":"2022-09-23","current":-0.424619,"twenty":-20.264397,"median":-5.617506,"eighty":-1.411407,"marketCap":59738805},{"date":"2022-09-30","current":-0.416374,"twenty":-20.264397,"median":-5.617506,"eighty":-1.411407,"marketCap":58578828},{"date":"2022-10-07","current":-0.44317,"twenty":-20.264397,"median":-5.617506,"eighty":-1.411407,"marketCap":62348753},{"date":"2022-10-14","current":-0.432864,"twenty":-20.264397,"median":-5.617506,"eighty":-1.411407,"marketCap":60898782},{"date":"2022-10-21","current":-0.391639,"twenty":-20.264397,"median":-5.617506,"eighty":-1.411407,"marketCap":55098898},{"date":"2022-10-28","current":-0.331862,"twenty":-20.264397,"median":-5.617506,"eighty":-1.411407,"marketCap":46689066},{"date":"2022-11-04","current":-0.263841,"twenty":-20.264397,"median":-5.578166,"eighty":-1.380385,"marketCap":37119257},{"date":"2022-11-11","current":-0.346704,"twenty":-19.502415,"median":-5.558997,"eighty":-1.33688,"marketCap":48777024},{"date":"2022-11-18","current":-0.644124,"twenty":-19.064532,"median":-5.520659,"eighty":-1.256956,"marketCap":82358352},{"date":"2022-11-25","current":-0.585155,"twenty":-18.984541,"median":-5.492672,"eighty":-1.212912,"marketCap":74818503},{"date":"2022-12-02","current":-0.635052,"twenty":-18.717904,"median":-5.482321,"eighty":-1.151957,"marketCap":81198376},{"date":"2022-12-09","current":-0.675877,"twenty":-18.18463,"median":-5.443983,"eighty":-1.101442,"marketCap":86418271},{"date":"2022-12-16","current":-0.503505,"twenty":-17.118083,"median":-5.424814,"eighty":-1.065773,"marketCap":64378712},{"date":"2022-12-23","current":-0.483093,"twenty":-16.344836,"median":-5.386476,"eighty":-1.028903,"marketCap":61768764},{"date":"2022-12-30","current":-0.479691,"twenty":-12.032791,"median":-5.367307,"eighty":-0.966404,"marketCap":61333773},{"date":"2023-01-06","current":-0.596495,"twenty":-12.032791,"median":-5.367307,"eighty":-0.966404,"marketCap":76268474},{"date":"2023-01-13","current":-0.623712,"twenty":-12.032791,"median":-5.367307,"eighty":-0.966404,"marketCap":79748405},{"date":"2023-01-20","current":-0.675877,"twenty":-12.032791,"median":-5.367307,"eighty":-0.966404,"marketCap":86418271},{"date":"2023-01-27","current":-0.679279,"twenty":-12.032791,"median":-5.367307,"eighty":-0.966404,"marketCap":86853262},{"date":"2023-02-03","current":-0.501237,"twenty":-12.032791,"median":-5.367307,"eighty":-0.966404,"marketCap":64088718},{"date":"2023-02-10","current":-0.462681,"twenty":-12.032791,"median":-5.367307,"eighty":-0.966404,"marketCap":59158816},{"date":"2023-02-17","current":-0.376495,"twenty":-12.032791,"median":-5.367307,"eighty":-0.966404,"marketCap":48139037},{"date":"2023-02-24","current":-0.325464,"twenty":-12.032791,"median":-5.367307,"eighty":-0.966404,"marketCap":41614167},{"date":"2023-03-03","current":-0.311856,"twenty":-12.032791,"median":-5.367307,"eighty":-0.966404,"marketCap":39874202},{"date":"2023-03-10","current":-0.221134,"twenty":-12.032791,"median":-5.367307,"eighty":-0.966404,"marketCap":28274434},{"date":"2023-03-17","current":-0.196186,"twenty":-12.032791,"median":-5.367307,"eighty":-0.966404,"marketCap":25084498},{"date":"2023-03-24","current":-0.23701,"twenty":-7.912833,"median":-5.328969,"eighty":-0.934805,"marketCap":30304393},{"date":"2023-03-31","current":-0.23599,"twenty":-7.799657,"median":-5.300216,"eighty":-0.905745,"marketCap":30173896},{"date":"2023-04-06","current":-0.22,"twenty":-7.736321,"median":-5.271462,"eighty":-0.89745,"marketCap":28129437},{"date":"2023-04-14","current":-0.193918,"twenty":-7.618138,"median":-5.213956,"eighty":-0.869161,"marketCap":24794504},{"date":"2023-04-21","current":-0.21433,"twenty":-7.544574,"median":-5.175618,"eighty":-0.862248,"marketCap":27404451},{"date":"2023-04-28","current":-0.206392,"twenty":-7.475746,"median":-5.13728,"eighty":-0.853615,"marketCap":26389472},{"date":"2023-05-05","current":-0.145166,"twenty":-7.414639,"median":-5.079773,"eighty":-0.84702,"marketCap":18561078},{"date":"2023-05-12","current":-0.100939,"twenty":-7.326902,"median":-5.055811,"eighty":-0.831517,"marketCap":12906191},{"date":"2023-05-19","current":-0.089576,"twenty":-7.276543,"median":-5.005076,"eighty":-0.824164,"marketCap":11453320},{"date":"2023-05-26","current":-0.153093,"twenty":-7.234443,"median":-4.969091,"eighty":-0.804955,"marketCap":19574608},{"date":"2023-06-02","current":-0.309588,"twenty":-7.216666,"median":-4.950596,"eighty":-0.789981,"marketCap":39584208},{"date":"2023-06-09","current":-0.19165,"twenty":-7.176226,"median":-4.910647,"eighty":-0.693321,"marketCap":24504509},{"date":"2023-06-16","current":-0.164433,"twenty":-7.117882,"median":-4.893412,"eighty":-0.675877,"marketCap":21024579},{"date":"2023-06-23","current":-0.157629,"twenty":-7.116814,"median":-4.864454,"eighty":-0.665443,"marketCap":20154596},{"date":"2023-06-30","current":-0.104341,"twenty":-7.089592,"median":-4.849117,"eighty":-0.655464,"marketCap":13341183},{"date":"2023-07-07","current":-0.056701,"twenty":-7.077048,"median":-4.833867,"eighty":-0.636186,"marketCap":7249855},{"date":"2023-07-14","current":-0.058946,"twenty":-7.039621,"median":-4.806088,"eighty":-0.627114,"marketCap":7536949},{"date":"2023-07-21","current":-0.053968,"twenty":-7.001196,"median":-4.763696,"eighty":-0.612193,"marketCap":6900411},{"date":"2026-08-07","current":-13.67385,"twenty":-6.321469,"median":-0.849705,"eighty":-0.300743,"marketCap":876931366},{"date":"2026-08-14","current":-12.868717,"twenty":-6.321469,"median":-0.849705,"eighty":-0.300743,"marketCap":825296546},{"date":"2026-08-21","current":-13.55979,"twenty":-6.361566,"median":-0.849705,"eighty":-0.300743,"marketCap":869616433},{"date":"2026-08-28","current":-14.39847,"twenty":-6.395071,"median":-0.849705,"eighty":-0.300743,"marketCap":923402704},{"date":"2026-09-04","current":-16.236859,"twenty":-6.469667,"median":-0.849705,"eighty":-0.300743,"marketCap":1041302211},{"date":"2026-09-11","current":-14.613852,"twenty":-6.493497,"median":-0.849705,"eighty":-0.300743,"marketCap":1028522932},{"date":"2026-09-18","current":-14.74358,"twenty":-6.493497,"median":-0.849705,"eighty":-0.300743,"marketCap":1037653185},{"date":"2026-09-25","current":-11.785783,"twenty":-6.493497,"median":-0.849705,"eighty":-0.300743,"marketCap":829483430},{"date":"2026-10-02","current":-11.5393,"twenty":-6.493497,"median":-0.849705,"eighty":-0.300743,"marketCap":812135950},{"date":"2026-10-08","current":-10.650664,"twenty":-6.493497,"median":-0.849705,"eighty":-0.300743,"marketCap":749593722}],"updateTime":1791582656463},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ATTO\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2671505082","title":"Attovia Therapeutics to Present New Data on ATTO-1310 and ATTO-2306 at EADV 2026 and Fall Clinical Dermatology Conference 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2671505082","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671505082?lang=en_us&edition=fundamental","pubTime":"2026-09-29 04:05","pubTimestamp":1790625900,"startTime":"0","endTime":"0","summary":"SAN CARLOS, Calif., Sept.  28, 2026 (GLOBE NEWSWIRE) -- Attovia Therapeutics, Inc. (“Attovia”) (Nasdaq: ATTO), a clinical-stage biopharmaceutical company developing next-generation biotherapeutics for","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/28/3370251/0/en/attovia-therapeutics-to-present-new-data-on-atto-1310-and-atto-2306-at-eadv-2026-and-fall-clinical-dermatology-conference-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4132","BK4139","AD","BK4226","ATTO","BK4143"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664801902","title":"Attovia Therapeutics to Participate in Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2664801902","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664801902?lang=en_us&edition=fundamental","pubTime":"2026-09-04 04:05","pubTimestamp":1788465900,"startTime":"0","endTime":"0","summary":"SAN CARLOS, Calif., Sept.  03, 2026 (GLOBE NEWSWIRE) -- Attovia Therapeutics, Inc. (“Attovia” or the “Company”) (Nasdaq: ATTO), a clinical-stage biopharmaceutical company developing next-generation bi","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/03/3356250/0/en/attovia-therapeutics-to-participate-in-upcoming-investor-conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IAI","IE00BZ1G4Q59.USD","LU1548497426.USD","BK4226","LU0971096721.USD","LU1791710582.SGD","BK4143","IE00BKVL7J92.USD","LU0234570918.USD","LU1732800096.USD","LU2089283258.USD","LU1720051017.SGD","LU0053666078.USD","LU1989772923.USD","IE00B3S45H60.SGD","KBWB","LU1363072403.SGD","LU2264538146.SGD","LU2023251221.USD","LU1244550221.USD","LU1074936037.SGD","LU2487616109.SGD","BK4127","LU1989772840.SGD","BK4581","BK4516","LU1791710400.SGD","LU0106261372.USD","LU1244550577.SGD","LU2357305700.SGD","LU1668664300.SGD","LU1064131342.USD","LU2089284900.SGD","LU0098860793.USD","LU2111349929.HKD","BK4139","LU1162221912.USD","LU0390134368.USD","LU2028103732.USD","LU0912757837.SGD","LU1720051108.HKD","IE00B775SV38.USD","ATTO","LU0225283273.USD","LU0882574139.USD","LU1732799900.SGD","LU1988902786.USD","BK4585","LU0267386448.USD","LU0158827781.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664980313","title":"Sam Slutsky Reiterates Buy on Attovia, Maintains $45 Price Target on Strong Early ATTO-1310 Data and Robust Cash Runway","url":"https://stock-news.laohu8.com/highlight/detail?id=2664980313","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664980313?lang=en_us&edition=fundamental","pubTime":"2026-09-03 23:55","pubTimestamp":1788450925,"startTime":"0","endTime":"0","summary":"Sam Slutsky, an analyst from LifeSci Capital, maintained the Buy rating on Attovia Therapeutics, Inc.. The associated price target remains the same...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/sam-slutsky-reiterates-buy-on-attovia-maintains-45-price-target-on-strong-early-atto-1310-data-and-robust-cash-runway-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/sam-slutsky-reiterates-buy-on-attovia-maintains-45-price-target-on-strong-early-atto-1310-data-and-robust-cash-runway-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ATTO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664871433","title":"Analysts Offer Insights on NA Companies: Fastenal Company (FAST) and Attovia Therapeutics, Inc. (ATTO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664871433","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664871433?lang=en_us&edition=fundamental","pubTime":"2026-09-03 19:50","pubTimestamp":1788436209,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the NA sector with new ratings on Fastenal Company (FAST) and Attovia Therapeutics, Inc. (ATTO). Fastenal C...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-fastenal-company-fast-and-attovia-therapeutics-inc-atto-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-fastenal-company-fast-and-attovia-therapeutics-inc-atto-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4139","ATTO","IE00B5TLWC47.USD","BK4104","BK4143","NA","IE00BYQQ9H92.USD","BK4226","IE00BFXG0V08.USD","BK4585","BK4567","FAST","BK4141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664480849","title":"Attovia Q2 FY26 Net Loss Widens to $20.7 Million; Revenue Rises to $0.5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2664480849","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664480849?lang=en_us&edition=fundamental","pubTime":"2026-09-03 04:18","pubTimestamp":1788380284,"startTime":"0","endTime":"0","summary":"Attovia Q2 FY26 net loss widens to $20.7 million; revenue rises to $0.5 millionAttovia reported Q2 net loss widened 43.75% to $20.7 million, as R&D spending climbed 38.97% to $18.9 million.G&A expense","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL9j86nW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATTO","BK4226","BK4143","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664849610","title":"Attovia Therapeutics Q2 EPS $(4.88) Misses $(4.62) Estimate, Sales $450.000K","url":"https://stock-news.laohu8.com/highlight/detail?id=2664849610","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664849610?lang=en_us&edition=fundamental","pubTime":"2026-09-03 04:09","pubTimestamp":1788379777,"startTime":"0","endTime":"0","summary":"Attovia Therapeutics (NASDAQ:ATTO) reported quarterly losses of $(4.88) per share which missed the analyst consensus estimate of $(4.62) by 5.63 percent. This is a 31.54 percent decrease over losses of $(3.71) per share","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/09/61589253/attovia-therapeutics-q2-eps-4-88-misses-4-62-estimate-sales-450-000k","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Attovia Therapeutics Q2 EPS $(4.88) Misses $(4.62) Estimate, Sales $450.000K","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATTO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664849314","title":"Attovia Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2664849314","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664849314?lang=en_us&edition=fundamental","pubTime":"2026-09-03 04:05","pubTimestamp":1788379503,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nTUA9NCHCR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4143","BK4139","BK4226","ATTO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664849283","title":"Attovia Therapeutics - Q2 Collaboration Revenue was $0.50 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2664849283","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664849283?lang=en_us&edition=fundamental","pubTime":"2026-09-03 04:05","pubTimestamp":1788379503,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nTUA9NCHCR:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4143","BK4226","BK4139","ATTO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664684928","title":"Attovia Therapeutics - Q2 Net Loss was $20.70 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2664684928","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664684928?lang=en_us&edition=fundamental","pubTime":"2026-09-03 04:05","pubTimestamp":1788379503,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nTUA9NCHCR:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4143","ATTO","BK4226","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663004150","title":"Attovia Therapeutics Could Serve as Key Player in Immunology, Inflammation, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2663004150","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663004150?lang=en_us&edition=fundamental","pubTime":"2026-08-31 23:16","pubTimestamp":1788189373,"startTime":"0","endTime":"0","summary":"Attovia Therapeutics'  ATTOBODY platform should position the company as a key player in immunology and inflammation, RBC Capital Markets said in a Sunday note.The company uses ATTOBODY in designing and developing mono- or multi-specific biologics against validated targets, like its most advanced ATTO-1310 product candidate, which has the same target as Nemluvio, an approved therapy for atopic dermatitis, RBC said.ATTOBODY could line up a sustained portfolio for the company, with data on ATTO-1310 in chronic pruritus and high-itch atopic dermatitis expected in Q4 and Q1 2027, respectively, while a phase 1 study on ATTO-2306 in atopic dermatitis is slated for H1 2027, the brokerage noted. Both product candidates present more than $2 billion in peak global sales opportunity, RBC said.Attovia is also set to evaluate ATTO-1091 in hitting three high-validated inflammatory bowel disease targets, RBC added.RBC initiated coverage of Attovia Therapeutics with an outperform rating and $45 price t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BK4143","ATTO","BK4226"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663972004","title":"Attovia Therapeutics Initiated at Buy by Citigroup","url":"https://stock-news.laohu8.com/highlight/detail?id=2663972004","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663972004?lang=en_us&edition=fundamental","pubTime":"2026-08-31 23:15","pubTimestamp":1788189300,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ATTO/analyst-ratings","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATTO","BK4226","BK4143","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663530077","title":"Morgan Stanley Initiates Coverage on Attovia Therapeutics With Overweight Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2663530077","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663530077?lang=en_us&edition=fundamental","pubTime":"2026-08-31 19:05","pubTimestamp":1788174342,"startTime":"0","endTime":"0","summary":"Morgan Stanley Initiates Coverage on Attovia Therapeutics With Overweight Rating","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ATTO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663207499","title":"Attovia Therapeutics Inc : Leerink Partners Initiates Coverage with Outperform Rating; Target Price $52","url":"https://stock-news.laohu8.com/highlight/detail?id=2663207499","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663207499?lang=en_us&edition=fundamental","pubTime":"2026-08-31 18:23","pubTimestamp":1788171828,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44S00G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4143","BK4139","ATTO","BK4226"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663074968","title":"RBC Initiates Attovia Therapeutics at Outperform, Speculative Risk With $45 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2663074968","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663074968?lang=en_us&edition=fundamental","pubTime":"2026-08-31 18:21","pubTimestamp":1788171667,"startTime":"0","endTime":"0","summary":"RBC Initiates Attovia Therapeutics at Outperform, Speculative Risk With $45 Price Target","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ATTO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663407189","title":"Citigroup Initiates Attovia Therapeutics at Buy With $30 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2663407189","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663407189?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:49","pubTimestamp":1788169749,"startTime":"0","endTime":"0","summary":"Citigroup Initiates Attovia Therapeutics at Buy With $30 Price Target","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ATTO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663076251","title":"Attovia initiated with a Buy at Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2663076251","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663076251?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:15","pubTimestamp":1788167718,"startTime":"0","endTime":"0","summary":"Citi analyst Yigal Nochomovitz initiated coverage of Attovia (ATTO) with a Buy rating and $30 price target The firm says the company has a “partial...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/attovia-initiated-with-a-buy-at-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/attovia-initiated-with-a-buy-at-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4226","ATTO","BK4143","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663076221","title":"Attovia initiated with an Overweight at Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2663076221","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663076221?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:10","pubTimestamp":1788167405,"startTime":"0","endTime":"0","summary":"Morgan Stanley initiated coverage of Attovia (ATTO) with an Overweight rating and $39 price target The company’s focus on “de-risked targets” posit...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/attovia-initiated-with-an-overweight-at-morgan-stanley-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/attovia-initiated-with-an-overweight-at-morgan-stanley-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4143","BK4139","BK4226","ATTO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663020059","title":"U.S. Research Roundup-Adobe, Braveheart Bio, CACI International","url":"https://stock-news.laohu8.com/highlight/detail?id=2663020059","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663020059?lang=en_us&edition=fundamental","pubTime":"2026-08-31 15:24","pubTimestamp":1788161046,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Adobe, Braveheart Bio, CACI InternationalAug 31 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Adob","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL4N44S0J8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BRCC","PTGX","RKLB","BRVE","BW","TPZ","OHI","ATI","BPOP","EIX","PCG","HONA","SBRA","SCTX","ETR","PATH","MADE","RDW","RBRK","TROW","CRM","BAC","FTAG","LUNR","ASST","ADBE","AIRJ","IBM","HWAY","BURL","ANF","AFRU","CIEN","RVMD","FIVN","CACI","AFRM","DE","HQY","DLTR","ADSK","ATTO","ICE","MDB","XTL","KALU","SRE","BILT","BCDF","PYPL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663802723","title":"Attovia Therapeutics, Inc. (ATTO) Initiated with a Buy at RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2663802723","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663802723?lang=en_us&edition=fundamental","pubTime":"2026-08-31 14:25","pubTimestamp":1788157517,"startTime":"0","endTime":"0","summary":"Attovia Therapeutics, Inc. received a Buy rating and a $45.00 price target from RBC Capital analyst Brian Abrahams yesterday. According to TipRanks...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/attovia-therapeutics-inc-atto-initiated-with-a-buy-at-rbc-capital-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/attovia-therapeutics-inc-atto-initiated-with-a-buy-at-rbc-capital-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSIB","BK4139","LU0029864427.USD","LU0128525929.USD","LU0310800379.SGD","BK4226","BK4143","ATTO","LU0708994859.HKD","BK4207","LU1267930573.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659191283","title":"Goldman Sachs Reports Sale of 105,807 Attovia Therapeutics Shares Worth $2.22 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659191283","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659191283?lang=en_us&edition=fundamental","pubTime":"2026-08-14 09:52","pubTimestamp":1786672355,"startTime":"0","endTime":"0","summary":"Goldman Sachs reports sale of 105,807 Attovia Therapeutics shares worth $2.22 millionGoldman Sachs reported trading activity in Attovia Therapeutics common stock on Aug. 5, 2026.Purchased 85,000 share","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nNDL9TDGhQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Goldman Sachs Reports Sale of 105,807 Attovia Therapeutics Shares Worth $2.22 Million","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237438978.USD","LU2471134879.HKD","GSX","LU2471134952.CNY","LU0251131958.USD","LU2237443978.SGD","IE00BFXG1179.USD","LU2237443622.USD","LU2237443895.HKD","LU0742534661.SGD","LU0942090050.USD","LU2471134523.USD","LU0048573561.USD","LU1894683348.USD","IE00B19Z3581.USD","BK4552","BK4585","BK4588","BK4504","IE0004086264.USD","BK4533","LU1868836757.USD","LU1868836591.USD","IE00B19Z3B42.SGD","IE00BSNM7G36.USD","ATTO","LU0251142724.SGD","LU2750360997.AUD","IE0002270589.USD","LU0868494708.USD","LU1791807156.HKD","LU2265009873.SGD","LU0106831901.USD","BK4516","LU2237443549.SGD","LU1894683264.USD","BK4127","LU1804176565.USD","LU2471134796.USD","IE0034235188.USD","IE0004091025.USD","LU0345770993.USD","LU2237443382.USD","LU2750360641.GBP","BK4143","LU1868837136.USD","LU0868494617.USD","LU0061475181.USD","LU0345770308.USD","LU1868836914.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":35,"code":"91000000","status":"200"}]}}